Primeadine
Primeadine

Free to view

Video interview with BioViva’s Liz Parrish

BioViva and Integrated Health Systems: How many patients in...

Video interview with Dr Isabelle Schiffer on senolytic safety

Forever Healthy Foundation issues risk-benefit analysis on dasatinib +...

Neurotech is the new blue ocean

Alon Braun, Co-Founder, Neurotech Analytics.

Exclusive video interview: Human Longevity Inc.’s Chairman

After $0.5bn cumulative investment, Human Longevity Inc. pivots into high-end...

5 investment lessons from coronavirus

Sergey Young, Founder, Longevity Vision Fund.
Primeadine
lumen

Latest articles

Targeting inflammaging: the hidden “inflammapath” inside us

Keystone Bio seeks funding as it gears up for clinical trials of therapeutic targeting the “keystone pathogen” of chronic inflammaging. Lurking in the mouths of...

Hyperbaric oxygen therapy: a commercial Longevity treatment?

Hyperbaric oxygen therapy can significantly decrease aging characteristics – does it have a future as a commercial Longevity treatment? Aging is made up of many...

Senescence: a new weapon in the fight against cancer

Targeting senescent “zombie” cells may improve cancer survival rates. How well women with cervical cancer respond to treatment (and survive) correlates with the level of...

Wearables and AI on the frontline of Longevity

Disruptive platforms are set for huge growth ahead of the inevitable consolidation and acquisitions: the race is on. Rise and fall used to be the...